Testing valbenazine for adult hair-pulling disorder symptoms
Treatments studied
Part of Mental health clinical trials.
This Phase 2 study tests whether valbenazine can reduce symptoms of trichotillomania (a hair-pulling disorder) in adults. You may be able to join if your symptoms cause major distress or interfere with daily life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult age 18 to 65 and can give written consent to take part.
- Your mental health and physical exam (including blood tests and an ECG heart check) look acceptable.
- Your hair-pulling symptoms cause major distress or problems at work or socially.
- You must have a stable medication plan for at least 4 weeks before starting, with no expected changes during the study.
- If you can become pregnant, you must use reliable birth control and have repeated negative pregnancy tests.
- You must pass repeated drug and pregnancy screening (and avoid substances that can interfere with the study medicine).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether the medication aripiprazole (Abilify) can help reduce hair-pulling or skin-picking behaviors. It is a treatment for adults with trichotillomania or skin-picking disorder.
This study tests whether the medication semaglutide (also used for weight management) can help reduce the urge-driven hair pulling in trichotillomania. If you frequently pull your hair due to urges, this trial may offer a new way to help control that behavior.
This trial tests whether cognitive behavioral group therapy can help reduce hair pulling in people with trichotillomania. You may be offered group sessions that teach skills to understand and change hair-pulling habits.
This study tests if valbenazine, a medication that affects brain chemicals, can reduce OCD symptoms in adults. Participants must have moderate to severe OCD and take the pill daily for the study period.
This trial tests a mobile app (Keen2) to help people with trichotillomania (hair-pulling disorder) reduce their pulling urges. It may be a good fit if you have stable symptoms and own an iPhone.
This study tests if valbenazine helps adults with tardive dyskinesia whose symptoms continue even after taking or stopping another similar medication. Tardive dyskinesia involves uncontrollable movements from long-term use of certain mental health drugs.
Hear when a new Trichotillomania (Hair-Pulling Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.